| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |